Condition category
Mental and Behavioural Disorders
Date applied
06/12/2009
Date assigned
16/12/2009
Last edited
31/05/2011
Prospective/Retrospective
Retrospectively registered
Overall trial status
Stopped
Recruitment status
Stopped

Plain English Summary

Not provided at time of registration

Trial website

http://www.verbund-kinder-krebskranker-eltern.de

Contact information

Type

Scientific

Primary contact

Dr Birgit Moeller

ORCID ID

Contact details

University Medical Centre Hamburg-Eppendorf
Centre of Psychosocial Medicine
Department of Child and Adolescent Psychiatry and Psychotherapy
Martinistrasse 52
Hamburg
20246
Germany
+49 (0)40 7410 52243
bmoeller@uke.de

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

A randomised controlled trial of a manualised preventive counselling program for children of parents with cancer

Acronym

RCT COSIP

Study hypothesis

Evaluation of interventions’ effectiveness compared to waiting list control of a manualised child-focused preventive counselling program for children of parents with cancer.

Ethics approval

Ethics Committee of the Medical Association of Hamburg gave approval on October 15, 2009; (ref: PV3322)

Study design

Single centre randomised waiting list controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Other

Trial type

Treatment

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet.

Condition

Child and adolescent psychotherapy and psychiatry, psycho-oncology

Intervention

A manualised child-focused preventive counselling program consisting of
1. Evaluation of parent(s)
2. Evaluation of child or children
3. A maximum of six individually customised and focused sessions (e.g. further single sessions with one or each child or a parent alone, sessions with family, parents or siblings)

All outcomes will be measured before and after treatment, and at 6 month follow up

Intervention type

Other

Phase

Not Applicable

Drug names

Primary outcome measures

1. Children’s health-related quality of life with Kid-Screen (8-18 years) rated from children’s and parents’ view.
2. Children’s behavioural and emotional problems measured with Child Behaviour Checklist (1,5-5/ 6-18 years) rated from parents’ view and Youth Self Report (11-18 years) rated from children’s view

Secondary outcome measures

1. Parents’ self-rated anxiety and depression measured with Hospital Anxiety and Depression Scale (HADS)
2. Family Assessment Device (FAD) to measure familial functioning from parents’ perspective
3. Family Crisis-Oriented Personal Evaluation Scales (F-COPES) to measure familial coping behaviour in crisis situations
4. Freiburg Questionnaire of Coping with Illness (FKV) to measure parental coping with illness
5. Health Survey (SF-8) to measure parental quality of life
6. Strengths and Difficulties Questionnaire (SDQ) to measure children’s and adolescents (exposure through children’s self-rating and additionally parents’ view
7. Connor-Davidson Resilience Scale (CD-Risc) to measure six different resilience factors
8. Kid-Cope (13-18 years) to measure children’s and adolescent’s cognitive and behavioural coping with parents’ cancer disease
9. Ad hoc developed intervention program rating scales to evaluate specific intervention contents and satisfaction with intervention; ratings from parents’, children’s (over 11 years) and counsellors’ viewpoint

Overall trial start date

07/12/2009

Overall trial end date

30/03/2011

Reason abandoned

Participant recruitment issues

Eligibility

Participant inclusion criteria

1. Wishing/seeking support
2. At least one parent has cancer
3. At least one child between 0-21 years

Participant type

Patient

Age group

Other

Gender

Both

Target number of participants

140 families

Participant exclusion criteria

1. Neither parent has cancer (e. g. other chronic diseases)
2. No informed consent for study participation (the program is provided without study participation)
3. At least one parent has psychotic symptoms or a psychotic mental disorder (ICD-10 or DSM-IV)
4. Acute endangerment of child to self or others
5. Insufficient German language abilities
6. Insufficient mobility of ill parent (the program is then offered to other family members)

Recruitment start date

07/12/2009

Recruitment end date

30/03/2011

Locations

Countries of recruitment

Germany

Trial participating centre

University Medical Centre Hamburg-Eppendorf
Hamburg
20246
Germany

Sponsor information

Organisation

German Cancer Aid (Deutsche Krebshilfe e.V.) (Germany)

Sponsor details

Buschstr. 32
Bonn
53113
Germany
+49 (0)228 729900
deutsche@krebshilfe.de

Sponsor type

Charity

Website

http://www.krebshilfe.de

Funders

Funder type

Charity

Funder name

German Cancer Aid (Deutsche Krebshilfe) (Germany)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes